Book Anti HAV Test in Amravati | Hepatitis A Antibody Test

The Anti Hepatitis A Virus test is a blood test that detects antibodies against the Hepatitis A virus in the bloodstream, providing clinically essential information about whether an individual has been previously exposed to HAV, has active or recent infection, or has developed protective immunity through either natural infection or vaccination. The test measures two distinct antibody classes, IgM and IgG, which serve fundamentally different clinical purposes and are interpreted separately depending on the clinical question being asked. Hepatitis A is a highly contagious viral liver infection transmitted through the faecal-oral route, most commonly through consumption of contaminated water, raw or undercooked shellfish, fresh produce irrigated with contaminated water, and close contact with infected individuals. Unlike Hepatitis B and C, Hepatitis A does not cause chronic liver disease and almost always resolves completely with full hepatic recovery, but it can cause severe acute hepatitis with prolonged jaundice, fulminant hepatic failure in vulnerable individuals, and significant socioeconomic disruption particularly in children and working-age adults. In India, HAV infection is hyperendemic with near-universal exposure occurring in childhood in many regions due to inadequate sanitation and water supply infrastructure, resulting in high population-level immunity in older age groups. However, improving sanitation in urban areas is paradoxically creating a cohort of young adults who have escaped childhood infection and therefore lack natural immunity, making them susceptible to more severe symptomatic disease when exposed as adults. HAV vaccination is increasingly recommended for susceptible adults and travellers in India. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.

Doctors prescribe an Anti HAV test in the following situations: Diagnosing acute Hepatitis A infection in patients presenting with sudden onset jaundice, dark urine, pale stools, right upper quadrant pain, nausea, vomiting, and fever where anti-HAV IgM positivity confirms acute HAV as the cause of liver inflammation and guides symptomatic management, dietary counselling, and public health notification. Assessing immunity status before Hepatitis A vaccination in adults who may have been naturally exposed during childhood where anti-HAV IgG positivity confirms pre-existing immunity, avoiding unnecessary and costly vaccination in already immune individuals while identifying susceptible adults who require immunisation. Screening healthcare workers, food handlers, sewage workers, and childcare staff where documentation of HAV immunity is required for occupational health clearance, and where anti-HAV IgG testing identifies those who need vaccination to protect both themselves and vulnerable populations they serve. Evaluating pre-travel immunity in individuals planning travel to HAV-endemic regions including rural India, Southeast Asia, Africa, and Central America where confirmation of immunity status guides decisions regarding pre-travel HAV vaccination to prevent traveller's hepatitis, a common and potentially serious travel-related illness. Investigating community outbreaks of jaundice and acute hepatitis in schools, residential institutions, and food-related clusters where anti-HAV IgM testing across affected and exposed individuals confirms HAV as the causative agent, enables source identification, and guides outbreak control measures including emergency vaccination of susceptible contacts. Assessing post-vaccination immunity in immunocompromised patients including those with HIV, organ transplant recipients, and patients on immunosuppressive therapy where vaccine-induced antibody responses may be suboptimal and anti-HAV IgG testing after vaccination confirms whether protective immunity has been achieved.

The Anti HAV test measures IgM and IgG class antibodies against Hepatitis A virus in the blood, reported as reactive or non-reactive for each antibody class. The two classes provide distinct and complementary clinical information that together enable accurate interpretation of HAV exposure history and immune status. Non-Reactive for Both IgM and IgG A non-reactive result for both anti-HAV IgM and IgG indicates that the individual has neither current nor past HAV infection and has not developed immunity through vaccination. This finding identifies a fully susceptible individual who would benefit from HAV vaccination, particularly if they have occupational exposure risk, plan to travel to endemic regions, or have chronic liver disease where HAV superinfection carries a risk of fulminant hepatic failure. Anti-HAV IgM Reactive A reactive IgM result indicates acute or very recent HAV infection, as IgM antibodies appear within the first week of symptoms and typically remain detectable for three to six months. This finding confirms the diagnosis of acute Hepatitis A and requires clinical management including rest, hydration, dietary modification, avoidance of hepatotoxic medications and alcohol, and notification of close contacts who may benefit from post-exposure prophylaxis with HAV vaccine or immunoglobulin. Anti-HAV IgG Reactive with Negative IgM A reactive IgG result with non-reactive IgM indicates past HAV infection or successful vaccination with established long-term protective immunity. IgG antibodies develop within two to three weeks of infection or vaccination and persist lifelong, conferring durable protection against reinfection. This finding effectively rules out current acute HAV infection and confirms that no vaccination is required in this individual.

No fasting is required for the Anti HAV test, as food and fluid intake do not affect hepatitis antibody concentrations in the blood. The test can be performed at any time of day and is typically ordered as part of an acute hepatitis workup, a pre-vaccination immunity assessment, or an occupational health screening panel without any specific dietary preparation needed beforehand. Inform your doctor about any recent HAV vaccination received within the past two to four weeks, as recently administered vaccine can produce a transient detectable IgM response in some assay platforms that may be misinterpreted as acute natural infection. Documenting the precise vaccination date allows accurate distinction between vaccine-induced and infection-induced antibody responses. Inform your doctor about all immunosuppressive medications and biological therapies currently being taken, as these agents impair antibody production and may produce false negative results in both IgM and IgG testing, underestimating true exposure and immunity status. If the test is being performed as part of an acute hepatitis investigation, documenting the precise onset date of symptoms and jaundice enables accurate interpretation of IgM results relative to the expected window of antibody detectability. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.

If you are booking through the SecondMedic platform the Anti HAV test price in Amravati can cost you around Rs. 737. You may also consider booking a comprehensive acute hepatitis panel that includes Anti HAV alongside HBsAg, Anti HCV, liver function tests, and viral hepatitis markers for a complete evaluation of acute liver inflammation at a bundled price on SecondMedic.

SecondMedic offers convenient home sample collection for the Anti HAV test in Amravati, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.